Bibliometric analysis of Tumor infiltrating lymphocytes therapy
Integrate Medicine · 31.07.2025
DOI: 10.61958/imjp7729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 31.07.2025. Verfasst von Fei-Fei Shang. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Objective
Tumor infiltrating lymphocytes (TILs) are immune cells within the tumor microenvironment that can either attack tumor cells or suppress immune responses, aiding tumor escape. TIL therapy extracts these lymphocytes from tumor tissue, expands them in vitro, and reinfuses them into the patient, making them a promising treatment for solid tumors. This study aims to analyze global research trends in TIL therapy using bibliometric methods to identify key contributors, institutions, journals, and emerging research focuses.
Methods
This bibliometric analysis examines trends in TIL therapy research using Web of Science literature, analyzed with VOS viewer, Pajek, Microsoft Excel, and Endnote.
Results
The United States leads in productivity, with The University of Texas MD Anderson Cancer Center as the top institution, Clinical Cancer Research as a key journal, and Rosenberg Steven Aaron as the most prolific author. Keyword analysis highlights a focus on immunotherapy and TILs, investigating their mechanisms and modalities.
Conclusions
TIL therapy research is expanding rapidly, led by the U.S. and key institutions. Despite its potential, challenges remain in production, standardization, and clinical translation. Future work should focus on improving efficiency, patient selection, and combination strategies.
Zitieren
APA
Shang, F. (2025). Bibliometric analysis of Tumor infiltrating lymphocytes therapy. Integrate Medicine. https://doi.org/10.61958/imjp7729
Vancouver
Shang F. Bibliometric analysis of Tumor infiltrating lymphocytes therapy. Integrate Medicine. 2025. doi:10.61958/imjp7729
BibTeX
@article{Shang2025,
author = {Shang, Fei-Fei},
title = {Bibliometric analysis of Tumor infiltrating lymphocytes therapy},
journal = {Integrate Medicine},
year = {2025},
doi = {10.61958/imjp7729}
}
EUVIMED